One week left to submit an abstract for #Tandem25 and showcase your work to fellow professionals in the field. Don't delay—submissions close at 11:59 p.m. CT on Wednesday, October 9! https://lnkd.in/gBEHuNie
CIBMTR (Center for International Blood & Marrow Transplant Research)
Research Services
Milwaukee, WI 2,307 followers
Sharing knowledge. Sharing hope.
About us
CIBMTR® (Center for International Blood and Marrow Transplant Research®) is a research collaboration between the Medical College of Wisconsin (MCW) and NMDP. CIBMTR collaborates with the global scientific community to advance hematopoietic cell transplantation (HCT) and cellular therapy worldwide to increase survival and enrich quality of life for patients. CIBMTR facilitates critical observational and interventional research through scientific and statistical expertise, a large network of transplant centers, and a unique and extensive clinical outcomes database. Our prospective and observational research is accomplished through scientific and statistical expertise, a large network of transplant centers, and a clinical database of more than 630,000 patients. Support for the program is provided, in part, by grants and contracts from the National Institute of Health and Health Resources and Services Administration. Successful use of this funding has resulted in the completion of hundreds of studies that positively impact both clinical practice and transplant patients. CIBMTR is part of a robust, collaborative affiliation and outcomes-focused research endeavor. The CIBMTR Coordinating Center spans two campuses, in Milwaukee (CIBMTR MCW) and Minneapolis (CIBMTR NMDP), and is committed to supporting the highest level of clinical and health services research.
- Website
-
https://www.cibmtr.org/
External link for CIBMTR (Center for International Blood & Marrow Transplant Research)
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- Milwaukee, WI
- Type
- Nonprofit
- Founded
- 2004
- Specialties
- bone marrow transplantation, cellular therapy, bioinformatics, immunobiology, clinical outcomes research, HCT, statistical methodology, TCT Meetings, clinical trials, BMT CTN, health services research, RCI BMT, Blood and Marrow Transplant Clinical Trials Network, Resource for Clinical Investigation in Blood and Marrow Transplantation, BMT, SCTOD, Stem Cell Therapeutic Outcomes Database, CIDR, and Cellular Immunotherapy Data Resource
Locations
-
Primary
Get directions
9200 W. Wisconsin Avenue
Suite C5500
Milwaukee, WI 53226 , US
-
Get directions
500 N. 5th Street
Minneapolis, MN 55401-1206, US
Employees at CIBMTR (Center for International Blood & Marrow Transplant Research)
-
Bergetta Dietel
Clinical Data Manager at Be The Match/CIBMTR
-
Jeff Leszczynski, PMP
IT Project Manager/Program Manager | Healthcare | Financial | Information Systems | Project Management Professional (PMP)
-
Terita Buchanan-Moore, MBA
Industry Relations, Program Manager
-
Kathleen Malum
Supervisor, Data Operations at Be The Match operated by National Marrow Donor Program
Updates
-
CIBMTR and ASTCT are excited to announce that registration is now open for #Tandem25! Register early to receive the best rates. Learn more at: https://lnkd.in/gKC582iE
-
-
A recent CIBMTR study found that patients lived equally long after umbilical cord blood transplant, no matter their race. Read more about the study results: https://lnkd.in/gEdzhU3i
-
-
New CIBMTR Research – the first analysis from BMT CTN 1702! Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial. Read more, here: https://lnkd.in/gRgFxarN
-
Abstract submission for #Tandem25 is now open! Make sure to submit your latest HCT, cell, and/or gene therapy research by 11:59 p.m. PT on Oct. 9! Read more about abstract submission here: https://lnkd.in/gadWB2vi
-
-
JOB POSTING: CIBMTR is seeking a part time (0.1 FTE) Scientific Director to lead our Infection and Immune Reconstitution Working Committee. Learn more about this important position, here: https://lnkd.in/epGwTaSy
-
The largest ever long-term study of people who donated peripheral blood stem cells (#PBSC) show that medicines for these donations are safe. Learn more about this recent CIBMTR study: https://lnkd.in/gkPT5rKP
-
-
CIBMTR's August Newsletter is now available! Read about two of our working committees, the new OPTIMIZE study, the HLA_SAVE cumulative data extract, caregiver requirements for alloHCT, and much more. Read more online: https://lnkd.in/gTHQ9KKq
-
-
New CIBMTR research just published in American Society of Clinical Oncology (ASCO) Journal of Clinical Oncology: Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors. Read more: https://lnkd.in/g6nazk_t
Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors | Journal of Clinical Oncology
ascopubs.org
-
#COVID19 can be a dangerous infection, particularly in people who recently got #BMT or #CAR-T therapy. Revaccination after BMT is important to boost immunity. Learn more about this BMT CTN study: https://lnkd.in/gN9ue3jy
-